QuidelOrtho Corp (QDEL) operating KPIs
QDELNasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends January 1
Financials through Q2 FY2026, quarter ended Jun 28, 2026Last filing: 10-Q on Aug 7, 2026Score 6/3084% below fair value
$13.25−0.51 (-3.71%)
Close on Oct 30, 2026Market cap $908.62MP/E –Yield –
KPIs
Operating metrics that drive QuidelOrtho's business
| Countries of operation | Q3 22 |
|---|---|
| Countries of operation | 130 |
Counts and sizes QuidelOrtho tags in the notes of its 10-K and 10-Q filings (XBRL), as of the end of each quarter. Breakdowns follow the company's own labels; at most 15 are shown per metric. A fuller KPI sheet built from earnings releases and presentations is on the way. See how companies compare on these metrics.